Stockhead on MSN10h
Health Check: LTR Pharma finds fast-track path to US erectile dysfunction market
The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.
Superoxide's role in enzyme-driven drug synthesis uncovered
Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
FDA approves a new kind of oral antibiotic to treat urinary tract infections
Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
There’s a New Pill to Treat UTIs
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
3 BRILLIANT MINUTES: Building a better weight loss drug
Ozempic and Wegovy can have side effects because they target organs besides the brain. If only scientists found an enzyme ...